PMID- 28415406 OWN - NLM STAT- MEDLINE DCOM- 20170724 LR - 20170724 IS - 1873-0191 (Electronic) IS - 0928-4931 (Linking) VI - 75 DP - 2017 Jun 1 TI - PCL foamed scaffolds loaded with 5-fluorouracil anti-cancer drug prepared by an eco-friendly route. PG - 1191-1197 LID - S0928-4931(16)31695-2 [pii] LID - 10.1016/j.msec.2017.03.011 [doi] AB - This study describes a new preparation method, which combines freeze drying and supercritical CO(2) foaming approaches, for the preparation of drug delivery scaffolds of polycaprolactone loaded with 5-fluorouracil, an anti-cancer drug, with low solubility in scCO(2). It is a principal objective of this work to design a scCO(2) strategy to reduce 5-Fu solubility limitations in its homogeneous distribution into a PCL scaffold through the design of an innovative processing method. The design of this process is considered valuable for the development of clean technology in pharmacy and medicine, since most of the active agents have a null solubility in scCO(2).Supercritical CO(2) is used as a blowing agent to induce polymer foaming by means of the low temperature pressure quench process. The resulting samples have been prepared under different operational conditions focused on enhancing the performance of the release process. In this case, design of experiments (DOE) was considered for a more comprehensive and systematic optimization of the product. In particular, drug amount, equals to 4.8 or 9.1wt%, process temperature, of 45 or 50 degrees C and depressurization rate, equals to 0.1MPas(-1) or 2MPas(-1) were selected as the factors to be investigated by a three-factor at two-level full factorial design. Samples were characterized to establish porosity data, drug loading percentage and, especially, release profile chromatographically monitored. Results from DOE have concluded which are the best samples providing a sustained drug release for several days, which may be of great interest to develop materials for tissue engineering and sustained release applications. CI - Copyright (c) 2017 Elsevier B.V. All rights reserved. FAU - Salerno, Aurelio AU - Salerno A AD - Institut de Ciencia de Materials de Barcelona (CSIC), Campus de la UAB, 08193 Bellaterra, Spain; Centre for Advanced Biomaterials for Health Care, Istituto Italiano di Tecnologia, Largo Barsanti e Matteucci 53, 80125 Napoli, Italy. Electronic address: asalerno@unina.it. FAU - Domingo, Concepcion AU - Domingo C AD - Institut de Ciencia de Materials de Barcelona (CSIC), Campus de la UAB, 08193 Bellaterra, Spain. Electronic address: conchi@icmab.es. FAU - Saurina, Javier AU - Saurina J AD - Department of Analytical Chemistry, University of Barcelona, Marti i Franques 1-11, 08028 Barcelona, Spain. LA - eng PT - Journal Article DEP - 20170306 PL - Netherlands TA - Mater Sci Eng C Mater Biol Appl JT - Materials science & engineering. C, Materials for biological applications JID - 101484109 RN - 0 (Antineoplastic Agents) RN - 0 (Drug Carriers) RN - 0 (Polyesters) RN - 24980-41-4 (polycaprolactone) RN - U3P01618RT (Fluorouracil) SB - IM MH - *Antineoplastic Agents/chemistry/pharmacokinetics/pharmacology MH - *Drug Carriers/chemical synthesis/chemistry/pharmacokinetics/pharmacology MH - *Fluorouracil/chemistry/pharmacokinetics/pharmacology MH - *Polyesters/chemistry/pharmacokinetics/pharmacology OTO - NOTNLM OT - 5-Fluoracilo OT - Drug delivery OT - Polycaprolactone OT - Scaffolds OT - Supercritical CO(2) EDAT- 2017/04/19 06:00 MHDA- 2017/07/25 06:00 CRDT- 2017/04/19 06:00 PHST- 2016/10/10 00:00 [received] PHST- 2017/02/06 00:00 [revised] PHST- 2017/03/02 00:00 [accepted] PHST- 2017/04/19 06:00 [entrez] PHST- 2017/04/19 06:00 [pubmed] PHST- 2017/07/25 06:00 [medline] AID - S0928-4931(16)31695-2 [pii] AID - 10.1016/j.msec.2017.03.011 [doi] PST - ppublish SO - Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:1191-1197. doi: 10.1016/j.msec.2017.03.011. Epub 2017 Mar 6.